PMID: 9547165Apr 18, 1998Paper

Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype

Neuroscience Letters
S J AllenD Dawbarn

Abstract

Apolipoprotein E (ApoE) is a potent risk factor for Alzheimer's disease. Since the loss of cholinergic function in Alzheimer's disease is known to occur at an early stage in the disease we have examined this function in normal subjects with an Apoepsilon4 allele to see if the deficit occurs in the absence of Alzheimer pathology or symptoms. We report that brain tissue obtained post-mortem from normal subjects and Alzheimer patients with an Apoepsilon4 allele has a lower cholinergic activity than tissue from those subjects without this allele. This has important significance for the interpretation of the cholinergic deficits found in Alzheimer's disease.

References

Sep 1, 1976·Brain : a Journal of Neurology·D M BowenA N Davison
May 11, 1991·Lancet·P R WenhamG Blandell
Feb 20, 1982·Lancet·J S BentonJ S Snowden
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D E SchmechelA D Roses
Oct 13, 1995·Neuroscience Letters·I GordonD M Michaelson
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·J PoirierS Gauthier
Jan 17, 1996·Annals of the New York Academy of Sciences·U Beffert, J Poirier
Jul 1, 1997·Psychopharmacology·R Anderson, G A Higgins

❮ Previous
Next ❯

Citations

Jan 17, 2002·The Journal of Comparative Neurology·Elliott J MufsonJeffrey H Kordower
Jul 11, 2009·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Marina Del PretePaola Angelelli
Jan 24, 2002·Neurobiology of Aging·M RiemenschneiderA Kurz
Apr 13, 1999·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·O KleifeldD M Michaelson
Jun 27, 2003·Journal of Cardiothoracic and Vascular Anesthesia·George N DjaianiUNKNOWN CARE Investigators of the Duke Heart Center
Mar 25, 2010·Journal of the International Neuropsychological Society : JINS·Ivar ReinvangThomas Espeseth
Oct 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·G O'MearaD Wynick
Mar 5, 2008·Alzheimer Disease and Associated Disorders·Valéria Santoro BahiaRicardo Nitrini
Feb 3, 1999·Annals of the New York Academy of Sciences·E J MufsonD C Deecher
Apr 9, 2011·Dementia and Geriatric Cognitive Disorders·Emma L JonesClive G Ballard
Aug 4, 2009·Future Lipidology·Elena Posse de Chaves, Vasanthy Narayanaswami
Nov 17, 2009·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Barbara C van MunsterSophia E J A de Rooij
May 25, 2013·Neuroscience and Biobehavioral Reviews·Ivar ReinvangLars Tjelta Westlye
Jan 15, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Gerard J MarekRobert A Lenz
Oct 19, 2004·Journal of Neuroscience Methods·Lai Khai SiewShelley Jane Allen
May 20, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Ying LiuLan Tan
Oct 31, 2002·Human Psychopharmacology·Kurt Heininger
Jan 22, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nunzio PomaraJohn J Sidtis
Aug 31, 2007·Psychiatric Genetics·Barbara C van MunsterAeilko H Zwinderman
Oct 11, 2008·Cell Biochemistry and Function·Tania MarcourakisCristoforo Scavone
Feb 17, 2009·International Review of Psychiatry·David Meagher
Jul 22, 2008·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Judes Poirier
Aug 24, 2019·Frontiers in Aging Neuroscience·Yuan LiUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Sep 27, 2003·Alzheimer Disease and Associated Disorders·D F SwaabR W H Verwer
Jun 26, 2004·Journal of Neuropathology and Experimental Neurology·Shiyong PengMargaret Fahnestock
Mar 3, 2021·Applied Neuropsychology. Adult·Brian George CollinSteve Katsikas
Feb 3, 2005·Neurobiology of Disease·Chunsheng WangPatrick M Sullivan
Jun 28, 2005·Neurobiology of Aging·Seth LoveShelley J Allen
Apr 27, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Nunzio PomaraJohn J Sidtis

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.